Income Statement 9 Meters Biopharma, Inc.

Equities

NMTRQ

US6544052086

Investment Holding Companies

Market Closed - OTC Markets Other stock markets 10:33:22 10/09/2024 pm IST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

25/03	North American Morning Briefing : Tech in Focus on -2-	DJ
2023	Bidding Procedure Approved for 9 Meters Biopharma, Inc.	CI

0ae684b3cbb0783fe22db0ff.t7a8M-iXQx7zdAjL3AYzlC-aQ6jHBe0TIScNubRCWlg.9On5Yb6vB1O2BHu7rUlA2UnyEtn2dIVLbn5p0owHMR-P2ItlpsAERJ0GQQ

Published financial data: 9 METERS BIOPHARMA, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2018	2019	2020	2021	2022
Selling General & Admin Expenses, Total	10.66M	10.57M	9.72M	9.26M	11.01M
R&D Expenses	7.41M	13.72M	10.93M	22M	31.01M
Other Operating Expenses, Total	18.07M	24.28M	20.65M	31.26M	42.02M
Operating Income	-18.07M	-24.28M	-20.65M	-31.26M	-42.02M
Interest Expense, Total	-6.15M	-1.83M	-4.05M	-47.19K	-2.67M
Interest And Investment Income	164K	185K	18.99K	22.71K	501K
Net Interest Expenses	-5.99M	-1.64M	-4.03M	-24.48K	-2.17M
Other Non Operating Income (Expenses)	50K	-76.98K	-3.75M	7K	437K
EBT, Excl. Unusual Items	-24.01M	-26M	-28.43M	-31.28M	-43.75M
In Process R&D Expenses	-	-	-32.27M	-5.1M	-
Other Unusual Items	-154K	-1.05M	-800K	-400K	-20.3K
EBT, Incl. Unusual Items	-24.16M	-27.05M	-61.5M	-36.78M	-43.77M
Earnings From Continuing Operations	-24.16M	-27.05M	-61.5M	-36.78M	-43.77M
Net Income to Company	-24.16M	-27.05M	-61.5M	-36.78M	-43.77M
Net Income - (IS)	-24.16M	-27.05M	-61.5M	-36.78M	-43.77M
Net Income to Common Incl Extra Items	-24.16M	-27.05M	-61.5M	-36.78M	-43.77M
Net Income to Common Excl. Extra Items	-24.16M	-27.05M	-61.5M	-36.78M	-43.77M
Per Share Items
Net EPS - Basic	-19.52	-16.23	-11.64	-3.03	-3.38
Basic EPS - Continuing Operations	-19.52	-16.23	-11.64	-3.03	-3.38
Basic Weighted Average Shares Outstanding	1.24M	1.67M	5.28M	12.16M	12.96M
Net EPS - Diluted	-19.52	-16.23	-11.64	-3.03	-3.38
Diluted EPS - Continuing Operations	-19.52	-16.23	-11.64	-3.03	-3.38
Diluted Weighted Average Shares Outstanding	1.24M	1.67M	5.28M	12.16M	12.96M
Normalized Basic EPS	-12.12	-9.75	-3.36	-1.61	-2.11
Normalized Diluted EPS	-12.12	-9.75	-3.36	-1.61	-2.11
Supplemental Items
EBITDA	-18.05M	-24.26M	-20.63M	-31.25M	-42.01M
EBITA	-18.07M	-24.28M	-20.65M	-31.26M	-42.02M
EBIT	-18.07M	-24.28M	-20.65M	-31.26M	-42.02M
EBITDAR	-	-24.2M	-20.57M	-31.18M	-41.94M
Normalized Net Income	-15.01M	-16.25M	-17.77M	-19.55M	-27.34M
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	10.66M	10.51M	9.66M	9.19M	10.94M
Research And Development Expense From Footnotes	7.56M	13.72M	43.2M	27.1M	31.01M
Net Rental Expense, Total	-	60K	64.8K	71.52K	71.52K
Imputed Operating Lease Interest Expense	-	208K	1.21M	135K	153K
Imputed Operating Lease Depreciation	-	-148K	-1.15M	-63.91K	-81.88K
Stock-Based Comp., R&D Exp. (Total)	2.44M	908K	1.82M	773K	950K
Stock-Based Comp., G&A Exp. (Total)	1.36M	1.96M	2.9M	1.64M	2.99M
Total Stock-Based Compensation	3.8M	2.87M	4.72M	2.41M	3.94M

Fiscal Period: December	2018	2019	2020	2021	2022
Assets
Cash And Equivalents	5.73M	4.59M	37.85M	46.99M	12.65M
Total Cash And Short Term Investments	5.73M	4.59M	37.85M	46.99M	12.65M
Notes Receivable	-	-	-	-	-
Total Receivables	-	-	-	-	-
Prepaid Expenses	505K	555K	1M	2.99M	3.36M
Restricted Cash	-	-	-	-	17.01M
Other Current Assets, Total	180K	75K	75K	-	-
Total Current Assets	6.41M	5.22M	38.93M	49.99M	33.02M
Gross Property Plant And Equipment	61.24K	116K	287K	252K	200K
Accumulated Depreciation	-26.15K	-47.76K	-61.46K	-69.03K	-77.55K
Net Property Plant And Equipment	35.1K	68.25K	226K	183K	123K
Other Long-Term Assets, Total	5.58K	5.58K	5.58K	5.58K	7.28K
Total Assets	6.45M	5.3M	39.16M	50.17M	33.15M
Liabilities
Accounts Payable, Total	3.62M	3.89M	1.49M	2.43M	5.05M
Accrued Expenses, Total	928K	4.75M	5.29M	5.97M	4.38M
Short-term Borrowings	5.2M	3.18M	14.22K	-	-
Current Portion of Long-Term Debt	-	-	-	-	19.62M
Current Portion of Leases	-	42.83K	48.63K	54.8K	61.75K
Other Current Liabilities	370K	3.05M	7K	-	1.58M
Total Current Liabilities	10.11M	14.91M	6.85M	8.46M	30.7M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	-	-	168K	113K	51.4K
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	10.11M	14.91M	7.02M	8.57M	30.75M
Common Stock, Total	2.61K	3.95K	20.46K	25.82K	1.3K
Additional Paid In Capital	39.85M	60.95M	164M	210M	215M
Retained Earnings	-43.52M	-70.56M	-132M	-169M	-213M
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	-3.66M	-9.61M	32.14M	41.6M	2.4M
Total Equity	-3.66M	-9.61M	32.14M	41.6M	2.4M
Total Liabilities And Equity	6.45M	5.3M	39.16M	50.17M	33.15M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.34M	2.07M	10.8M	12.91M	14.34M
ECS Total Common Shares Outstanding	1.3M	1.97M	10.23M	12.91M	13.04M
Book Value / Share	-2.81	-4.87	3.14	3.22	0.18
Tangible Book Value	-3.66M	-9.61M	32.14M	41.6M	2.4M
Tangible Book Value Per Share	-2.81	-4.87	3.14	3.22	0.18
Total Debt	5.2M	3.23M	231K	168K	19.73M
Net Debt	-532K	-1.37M	-37.62M	-46.83M	7.08M
Debt Equivalent Oper. Leases	-	480K	518K	572K	572K
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	33.8K	45.73K	42.65K	55.13K	57.97K
Full Time Employees	8	8	12	21	10

Fiscal Period: December	2018	2019	2020	2021	2022
Net Income	-24.16M	-27.05M	-61.5M	-36.78M	-43.77M
Depreciation & Amortization - CF	19.56K	21.61K	18.49K	7.57K	8.52K
Depreciation & Amortization, Total	19.56K	21.61K	18.49K	7.57K	8.52K
Amortization of Deferred Charges, Total - (CF)	5.59M	1.17M	3.72M	43.98K	1.83M
(Gain) Loss From Sale Of Asset	-	-	39.2K	-	-
Asset Writedown & Restructuring Costs	-	-	28.75M	2.61M	-
Stock-Based Compensation (CF)	3.8M	2.87M	4.72M	2.41M	3.94M
Other Operating Activities, Total	230K	1.13M	4.06M	-7K	83.64K
Change In Accounts Payable	86.41K	125K	-2.47M	1.05M	2.62M
Change in Other Net Operating Assets	-740K	3.77M	3.24M	1.18M	-1.96M
Cash from Operations	-15.17M	-17.97M	-19.41M	-29.48M	-37.24M
Capital Expenditure	-13.94K	-11.93K	-2.54K	-12.48K	-2.84K
Sale (Purchase) of Intangible assets	-	-	-3.18M	-2.49M	-
Other Investing Activities, Total	0	-	-	75K	-
Cash from Investing	-13.94K	-11.93K	-3.19M	-2.43M	-2.84K
Short Term Debt Issued, Total	3M	5M	2.5M	-	-
Long-Term Debt Issued, Total	345K	-	-	-	21M
Total Debt Issued	3.34M	5M	2.5M	-	21M
Short Term Debt Repaid, Total	-	-7.79M	-2.46M	-58.2K	-
Long-Term Debt Repaid, Total	-275K	-	-	-	-
Total Debt Repaid	-275K	-7.79M	-2.46M	-58.2K	-
Issuance of Common Stock	19.24M	20.74M	39.68M	44.01M	-
Issuance of Preferred Stock	-	-	22.56M	-	-
Other Financing Activities, Total	-1.76M	-1.1M	-6.42M	-2.9M	-1.09M
Cash from Financing	20.56M	16.84M	55.86M	41.05M	19.91M
Net Change in Cash	5.37M	-1.14M	33.26M	9.14M	-17.33M
Supplemental Items
Cash Interest Paid	280K	874K	62.91K	569	835K
Levered Free Cash Flow	-5.51M	-5.45M	-15.51M	-19.91M	-36.92M
Unlevered Free Cash Flow	-7.25M	-5.37M	-16.7M	-19.92M	-37.08M
Change In Net Working Capital	-229K	-6.82M	5.34M	300K	14.76M
Net Debt Issued / Repaid	3.07M	-2.79M	38.53K	-58.2K	21M

Fiscal Period: December	2018	2019	2020	2021	2022
Profitability
Return on Assets	-311.44	-258.31	-58.07	-43.74	-63.03
Return on Total Capital	1.09K	625.98	-99.35	-52.7	-82.19
Return On Equity %	305.2	407.57	-545.95	-99.75	-198.92
Return on Common Equity	305.2	407.57	-545.95	-99.75	-198.92
Short Term Liquidity
Current Ratio	0.63	0.35	5.68	5.91	1.08
Quick Ratio	0.57	0.31	5.53	5.56	0.41
Operating Cash Flow to Current Liabilities	-1.5	-1.21	-2.83	-3.49	-1.21
Long Term Solvency
Total Debt/Equity	-142.02	-33.57	0.72	0.4	821.87
Total Debt / Total Capital	337.97	-50.54	0.71	0.4	89.15
LT Debt/Equity	-	-	0.52	0.27	2.14
Long-Term Debt / Total Capital	-	-	0.52	0.27	0.23
Total Liabilities / Total Assets	156.69	281.51	17.92	17.08	92.76
EBIT / Interest Expense	-2.94	-13.3	-5.1	-662.42	-15.75
EBITDA / Interest Expense	-2.93	-13.26	-5.08	-660.74	-15.72
(EBITDA - Capex) / Interest Expense	-2.94	-13.27	-5.08	-661.01	-15.72
Total Debt / EBITDA	-0.29	-0.13	-0.01	-0.01	-0.47
Net Debt / EBITDA	0.03	0.06	1.83	1.5	-0.17
Total Debt / (EBITDA - Capex)	-0.29	-0.13	-0.01	-0.01	-0.47
Net Debt / (EBITDA - Capex)	0.03	0.06	1.83	1.5	-0.17
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	61.69	33.27	-13.88	51.45	34.42
EBITA, 1 Yr. Growth %	61.78	33.25	-13.88	51.35	34.42
EBIT, 1 Yr. Growth %	61.78	33.25	-13.88	51.35	34.42
Earnings From Cont. Operations, 1 Yr. Growth %	108.19	11.95	127.35	-40.19	19
Net Income, 1 Yr. Growth %	108.19	11.95	127.35	-40.19	19
Normalized Net Income, 1 Yr. Growth %	106.86	7.6	10.62	10.01	39.87
Diluted EPS Before Extra, 1 Yr. Growth %	-0.05	-16.83	-28.27	-74.01	11.65
Net Property, Plant and Equip., 1 Yr. Growth %	-13.79	94.48	231.06	-19.14	-32.84
Total Assets, 1 Yr. Growth %	708.3	-17.93	639.28	28.13	-33.93
Tangible Book Value, 1 Yr. Growth %	-69.95	162.75	-434.33	29.44	-94.23
Common Equity, 1 Yr. Growth %	-69.95	162.75	-434.33	29.44	-94.23
Cash From Operations, 1 Yr. Growth %	197.64	18.45	8.02	51.87	26.34
Capital Expenditures, 1 Yr. Growth %	-64	-14.41	-78.69	390.6	-77.22
Levered Free Cash Flow, 1 Yr. Growth %	797.52	-2.78	194.76	28.38	85.45
Unlevered Free Cash Flow, 1 Yr. Growth %	1.81K	-26.88	221.89	19.31	86.14
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	82.57	47.42	6.47	14.2	42.68
EBITA, 2 Yr. CAGR %	82.65	47.45	6.46	14.16	42.63
EBIT, 2 Yr. CAGR %	82.65	47.45	6.46	14.16	42.63
Earnings From Cont. Operations, 2 Yr. CAGR %	107.35	52.66	59.54	16.61	-15.64
Net Income, 2 Yr. CAGR %	107.35	52.66	59.54	16.61	-15.64
Normalized Net Income, 2 Yr. CAGR %	106.69	49.67	8.47	10.32	24.05
Diluted EPS Before Extra, 2 Yr. CAGR %	134.03	-8.82	-22.76	-56.82	-46.13
Net Property, Plant and Equip., 2 Yr. CAGR %	112.57	29.49	153.74	63.62	-26.31
Total Assets, 2 Yr. CAGR %	276.36	157.56	146.32	207.77	-7.99
Tangible Book Value, 2 Yr. CAGR %	-25.47	-11.14	196.38	108.02	-72.67
Common Equity, 2 Yr. CAGR %	-25.47	-11.14	196.38	108.02	-72.67
Cash From Operations, 2 Yr. CAGR %	164.22	87.76	13.12	28.09	38.52
Capital Expenditures, 2 Yr. CAGR %	27.53	-44.49	-57.29	2.25	5.72
Levered Free Cash Flow, 2 Yr. CAGR %	-	197.96	66.35	94.53	54.3
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	275.85	50.72	95.97	49.02
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-	64.85	22.72	19.74	20.58
EBITA, 3 Yr. CAGR %	-	64.89	22.74	19.7	20.55
EBIT, 3 Yr. CAGR %	-	64.89	22.74	19.7	20.55
Earnings From Cont. Operations, 3 Yr. CAGR %	-	68.84	74.34	15.03	17.4
Net Income, 3 Yr. CAGR %	-	68.84	74.34	15.03	17.4
Normalized Net Income, 3 Yr. CAGR %	-	66.63	34.8	8.98	19.4
Diluted EPS Before Extra, 3 Yr. CAGR %	-	65.77	-15.83	-46.28	-40.74
Net Property, Plant and Equip., 3 Yr. CAGR %	-	106.36	77.06	73.32	21.6
Total Assets, 3 Yr. CAGR %	-	126.53	266.03	98.1	84.28
Tangible Book Value, 3 Yr. CAGR %	-	13.43	38.21	124.86	-37.03
Common Equity, 3 Yr. CAGR %	-	13.43	38.21	124.86	-37.03
Cash From Operations, 3 Yr. CAGR %	-	102.22	56.16	24.79	27.5
Capital Expenditures, 3 Yr. CAGR %	-	11.66	-59.66	-3.64	-38.02
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	193.45	52.58	91.45
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	252.73	39.43	92.64
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	-	-	41.99	30.35
EBITA, 5 Yr. CAGR %	-	-	-	41.99	30.34
EBIT, 5 Yr. CAGR %	-	-	-	41.99	30.34
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	45.6	30.4
Net Income, 5 Yr. CAGR %	-	-	-	45.6	30.4
Normalized Net Income, 5 Yr. CAGR %	-	-	-	40.96	30.39
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-3.22	-29.59
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	88.06	24.69
Total Assets, 5 Yr. CAGR %	-	-	-	156.07	110.69
Tangible Book Value, 5 Yr. CAGR %	-	-	-	44.57	-27.73
Common Equity, 5 Yr. CAGR %	-	-	-	44.57	-27.73
Cash From Operations, 5 Yr. CAGR %	-	-	-	68.46	48.85
Capital Expenditures, 5 Yr. CAGR %	-	-	-	7.79	-40.69
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	126.91
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	149.9